NIH-funded research R01 grant

Preventing congenital syphilis in pregnant people at risk in Rio de Janeiro

Official title: Evaluation of antimicrobial prophylaxis to prevent syphilis in pregnancy in patients at risk in Rio de Janeiro, Brazil

Funded at University of California Los Angeles · NIH-11399881 · Data updated 2026-11-12

A clinical trial will test a treatment approach during pregnancy to reduce syphilis transmission from mother to baby for pregnant people at risk in Rio de Janeiro.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startAugust 25, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$233,377
NIH project number5R01AI187414-02
Project IDNIH-11399881 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people in Rio de Janeiro who are at risk for syphilis and receiving prenatal care in disenfranchised areas.

Less likely to help

Individuals not at risk for syphilis or outside the study area may not benefit from this approach.

What this research studies

This trial will enroll pregnant individuals in Rio de Janeiro who are at risk for syphilis and randomize them to receive an antimicrobial prophylaxis strategy during pregnancy. The study builds on years of work in vertical transmission of infections and uses established local health systems to deliver care. If successful, the approach could reduce congenital syphilis and improve pregnancy outcomes for families in affected communities.

Why it matters

Potential benefit: If successful, mothers and babies could experience fewer syphilis-related health problems during and after pregnancy.

How similar studies have gone: Prior studies in related infectious-disease prevention and vertical transmission have informed this trial, with mixed but encouraging results in similar settings.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Nielsen, Karin — University of California Los Angeles
  • Study coordinator: Nielsen, Karin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.